Gene Bio Medical recaps their 2023 year
by CM Staff
With the ability to test over 40 subvariants of COVID-19, SwiftSwab expanded availability in major pharmacies underscores the company's commitment to making advanced healthcare solutions accessible to all.
SwiftSwab on-shelf (CNW Group/Gene Bio Medical)
TORONTO — Medical biotechnology manufacturer, Gene Bio Medical (GBM), says they have grown their position in 2023 in the healthcare space.
GBM’s COVID-19 Antigen Rapid Test, SwiftSwab is reportedly now available in Canadian pharmacies including Shoppers Drug Mart, Jean Coutu, PharmaSave, and Walmart Pharmacies, SwiftSwab is trying to deliver efficient solutions to urgent public health challenges. This rapid test’s widespread availability exemplifies GBM’s dedication to enhancing public health safety and its responsiveness to evolving healthcare needs.
With the ability to test over 40 subvariants of COVID-19, SwiftSwab expanded availability in major pharmacies underscores the company’s commitment to making advanced healthcare solutions accessible to all. This expansion is a strategic move to increase brand visibility and emphasize GBM’s role in public health management. SwiftSwab has reportedly been recognized and selling at over 440 pharmacies across Canada as of November 2023.
GBM’s work in Digital Enabled Point of Care Testing (POCT) using Molecularly Imprinted Polymer (MIP) technology represents a leap forward in diagnostic capabilities. These sensors are offering applications that span across medical diagnosis, environmental monitoring, food safety, and beyond.
In 2023, GBM forged significant partnerships with leading Canadian research hubs, including the CBRF PRAIRIE Hub at the University of Alberta, The University of British Columbia’s Immuno-Engineering and Biomanufacturing Hub, and the University of Toronto’s Canadian Hub for Health Intelligence & Innovation in Infectious Diseases. These collaborations are reportedly integral to GBM’s strategy in strengthening Canada’s biomanufacturing and life sciences sector and in building a robust foundation for future health security.
